vs
Side-by-side financial comparison of DIODES INC (DIOD) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
DIODES INC is the larger business by last-quarter revenue ($391.6M vs $270.4M, roughly 1.4× Enhabit, Inc.). DIODES INC runs the higher net margin — 2.6% vs -14.3%, a 16.9% gap on every dollar of revenue. On growth, DIODES INC posted the faster year-over-year revenue change (15.4% vs 4.7%). DIODES INC produced more free cash flow last quarter ($12.4M vs $3.3M). Over the past eight quarters, DIODES INC's revenue compounded faster (13.9% CAGR vs 1.5%).
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
DIOD vs EHAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $391.6M | $270.4M |
| Net Profit | $10.2M | $-38.7M |
| Gross Margin | 31.1% | — |
| Operating Margin | 3.4% | -12.3% |
| Net Margin | 2.6% | -14.3% |
| Revenue YoY | 15.4% | 4.7% |
| Net Profit YoY | 23.8% | 15.9% |
| EPS (diluted) | $0.23 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $391.6M | $270.4M | ||
| Q3 25 | $392.2M | $263.6M | ||
| Q2 25 | $366.2M | $266.1M | ||
| Q1 25 | $332.1M | $259.9M | ||
| Q4 24 | $339.3M | $258.2M | ||
| Q3 24 | $350.1M | $253.6M | ||
| Q2 24 | $319.8M | $260.6M | ||
| Q1 24 | $302.0M | $262.4M |
| Q4 25 | $10.2M | $-38.7M | ||
| Q3 25 | $14.3M | $11.1M | ||
| Q2 25 | $46.1M | $5.2M | ||
| Q1 25 | $-4.4M | $17.8M | ||
| Q4 24 | $8.2M | $-46.0M | ||
| Q3 24 | $13.7M | $-110.2M | ||
| Q2 24 | $8.0M | $-200.0K | ||
| Q1 24 | $14.0M | $200.0K |
| Q4 25 | 31.1% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 33.7% | — | ||
| Q2 24 | 33.6% | — | ||
| Q1 24 | 33.0% | — |
| Q4 25 | 3.4% | -12.3% | ||
| Q3 25 | 3.0% | 6.4% | ||
| Q2 25 | 2.6% | 6.3% | ||
| Q1 25 | 0.4% | 6.1% | ||
| Q4 24 | 3.5% | -16.0% | ||
| Q3 24 | 6.2% | -38.6% | ||
| Q2 24 | 1.2% | 4.3% | ||
| Q1 24 | 4.3% | 4.9% |
| Q4 25 | 2.6% | -14.3% | ||
| Q3 25 | 3.6% | 4.2% | ||
| Q2 25 | 12.6% | 2.0% | ||
| Q1 25 | -1.3% | 6.8% | ||
| Q4 24 | 2.4% | -17.8% | ||
| Q3 24 | 3.9% | -43.5% | ||
| Q2 24 | 2.5% | -0.1% | ||
| Q1 24 | 4.6% | 0.1% |
| Q4 25 | $0.23 | $-0.76 | ||
| Q3 25 | $0.31 | $0.22 | ||
| Q2 25 | $0.99 | $0.10 | ||
| Q1 25 | $-0.10 | $0.35 | ||
| Q4 24 | $0.18 | $-0.92 | ||
| Q3 24 | $0.30 | $-2.20 | ||
| Q2 24 | $0.17 | $0.00 | ||
| Q1 24 | $0.30 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $377.0M | $43.6M |
| Total DebtLower is stronger | $25.7M | $426.0M |
| Stockholders' EquityBook value | $1.9B | $534.0M |
| Total Assets | $2.4B | $1.2B |
| Debt / EquityLower = less leverage | 0.01× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $377.0M | $43.6M | ||
| Q3 25 | $386.4M | $56.9M | ||
| Q2 25 | $327.3M | $37.1M | ||
| Q1 25 | $343.9M | $39.5M | ||
| Q4 24 | $316.1M | $28.4M | ||
| Q3 24 | $319.3M | $45.7M | ||
| Q2 24 | $273.9M | $28.5M | ||
| Q1 24 | $276.0M | $36.5M |
| Q4 25 | $25.7M | $426.0M | ||
| Q3 25 | $24.9M | $441.5M | ||
| Q2 25 | $26.4M | $456.9M | ||
| Q1 25 | $20.5M | $467.3M | ||
| Q4 24 | $20.7M | $492.6M | ||
| Q3 24 | $22.2M | $502.9M | ||
| Q2 24 | $20.3M | $512.7M | ||
| Q1 24 | $20.9M | $526.7M |
| Q4 25 | $1.9B | $534.0M | ||
| Q3 25 | $1.9B | $566.8M | ||
| Q2 25 | $1.9B | $552.4M | ||
| Q1 25 | $1.8B | $543.2M | ||
| Q4 24 | $1.8B | $523.5M | ||
| Q3 24 | $1.8B | $566.1M | ||
| Q2 24 | $1.8B | $674.3M | ||
| Q1 24 | $1.7B | $672.3M |
| Q4 25 | $2.4B | $1.2B | ||
| Q3 25 | $2.5B | $1.2B | ||
| Q2 25 | $2.5B | $1.2B | ||
| Q1 25 | $2.4B | $1.2B | ||
| Q4 24 | $2.4B | $1.2B | ||
| Q3 24 | $2.4B | $1.3B | ||
| Q2 24 | $2.4B | $1.4B | ||
| Q1 24 | $2.4B | $1.4B |
| Q4 25 | 0.01× | 0.80× | ||
| Q3 25 | 0.01× | 0.78× | ||
| Q2 25 | 0.01× | 0.83× | ||
| Q1 25 | 0.01× | 0.86× | ||
| Q4 24 | 0.01× | 0.94× | ||
| Q3 24 | 0.01× | 0.89× | ||
| Q2 24 | 0.01× | 0.76× | ||
| Q1 24 | 0.01× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.1M | $4.4M |
| Free Cash FlowOCF − Capex | $12.4M | $3.3M |
| FCF MarginFCF / Revenue | 3.2% | 1.2% |
| Capex IntensityCapex / Revenue | 6.6% | 0.4% |
| Cash ConversionOCF / Net Profit | 3.74× | — |
| TTM Free Cash FlowTrailing 4 quarters | $137.2M | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.1M | $4.4M | ||
| Q3 25 | $79.1M | $37.8M | ||
| Q2 25 | $41.5M | $10.6M | ||
| Q1 25 | $56.7M | $17.9M | ||
| Q4 24 | $81.8M | $-4.1M | ||
| Q3 24 | $54.4M | $28.4M | ||
| Q2 24 | $14.4M | $9.6M | ||
| Q1 24 | $-31.1M | $17.3M |
| Q4 25 | $12.4M | $3.3M | ||
| Q3 25 | $62.8M | $36.2M | ||
| Q2 25 | $21.1M | $8.7M | ||
| Q1 25 | $40.8M | $17.6M | ||
| Q4 24 | $62.1M | $-4.7M | ||
| Q3 24 | $39.4M | $27.7M | ||
| Q2 24 | $-3.5M | $8.9M | ||
| Q1 24 | $-51.5M | $15.5M |
| Q4 25 | 3.2% | 1.2% | ||
| Q3 25 | 16.0% | 13.7% | ||
| Q2 25 | 5.8% | 3.3% | ||
| Q1 25 | 12.3% | 6.8% | ||
| Q4 24 | 18.3% | -1.8% | ||
| Q3 24 | 11.2% | 10.9% | ||
| Q2 24 | -1.1% | 3.4% | ||
| Q1 24 | -17.1% | 5.9% |
| Q4 25 | 6.6% | 0.4% | ||
| Q3 25 | 4.2% | 0.6% | ||
| Q2 25 | 5.6% | 0.7% | ||
| Q1 25 | 4.8% | 0.1% | ||
| Q4 24 | 5.8% | 0.2% | ||
| Q3 24 | 4.3% | 0.3% | ||
| Q2 24 | 5.6% | 0.3% | ||
| Q1 24 | 6.7% | 0.7% |
| Q4 25 | 3.74× | — | ||
| Q3 25 | 5.54× | 3.41× | ||
| Q2 25 | 0.90× | 2.04× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | 9.93× | — | ||
| Q3 24 | 3.95× | — | ||
| Q2 24 | 1.80× | — | ||
| Q1 24 | -2.22× | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
